HIV/AIDS Advocates Urge Brazil to Keep Pledge, Break Antiretroviral Patents
May 17, 2005
HIV/AIDS advocates on Friday protested outside the Brazilian embassy in Washington, D.C., and the Brazilian Mission to the United Nations in New York City to urge the Brazilian government to keep its pledge to break antiretroviral drug patents to produce generic versions of the medicines, the Advocate.com reports (Advocate.com, 5/14). The Brazilian government in March threatened to break the patents on four antiretrovirals by April 4 if the drug manufacturers did not agree to allow the country to produce generic equivalents or buy them at discounted prices, but it has not yet done so. The Brazilian government asked U.S. drug companies Merck, Gilead and Abbott Laboratories to grant the government voluntary licensing to produce generic versions of Merck's efavirenz, Abbott's lopinavir and ritonavir, and Gilead's tenofovir. Brazil's National STD/AIDS Programme, which is considered to be one of the most progressive in the world, already manufactures and distributes generic versions of antiretrovirals, providing them at no cost to all HIV-positive people in the country. The program ignores all patents issued before 1997, when Brazil signed an intellectual property law in order to join the World Trade Organization. The government over the past three years repeatedly has said it might break patent laws in order to negotiate price reductions with pharmaceutical companies (Kaiser Daily HIV/AIDS Report, 5/11). Members of ACT UP/New York, the Student Global AIDS Campaign, Health Global Access Project and the Global AIDS Alliance delivered a spine to Brazilian authorities, telling them to continue with plans to break the patents and provide less-expensive versions of antiretroviral medications, according to the Advocate.com.
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Senate Special Committee on Aging Hears Testimony on Growing Number of HIV-Positive People Older Than 50
Los Angeles County AIDS Office Director Demoted Following Investigation of Role in Fundraising for Mayoral Candidate
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.